The FCCB Committee approved the allotment of 48,11,730 (Forty Eight Lakhs Eleven Thousand Seven Hundred And Thirty) fully paid-up equity shares of face value ₹1/- each upon conversion of Foreign Currency Convertible Bonds (FCCBs) worth USD 15,00,000.
Capital Structure Impact
The conversion resulted in the following changes to the company's capital structure:
| Particulars | Pre-allotment | Post-allotment |
| Number of shares | 24,96,58,870 | 25,44,70,600 |
| Issued and Paid Up Capital (in ₹) | 24,96,58,870 | 25,44,70,600 |
Allotment Details (Annexure-I)
- Company name and address: Sudarshan Pharma Industries Limited, Reg. office: 301, Aura Biplex, Plot no. 7, Above Kalyan Jewellers, S. V. Road, Borivali West, Mumbai 400092
- Stock Exchange: BSE Limited
- Date of in-principle approval from BSE: 26th September 2025
- Par value of shares: ₹1/- per share
- Number of shares allotted: 48,11,730 shares
- Share Certificate No.: Not Applicable
- Issue price per share: ₹30.19 per share
- Premium per share: ₹29.19 per share
- Total issued shares after this issue: 25,44,70,600 equity shares
- Total issued share capital after this issue: ₹25,44,70,600
- Share characteristics: The shares allotted are identical in all respects to the existing equity shares of the Company and shall rank pari-passu with them from the date of allotment.
Meeting Details
The meeting of the FCCB Committee commenced at 5:15 pm and concluded at 6:00 pm on 19th August 2026.